OPTIMIZING MDM2 INHIBITION FOR THE TREATMENT OF HIGH-GRADE GLIOMA

被引：0
|
作者：
Rendo, Veronica [1 ]
Lupien, Leslie [2 ]
Khuu, Nicholas [3 ]
Pelton, Kristine [1 ]
Elcavage, Lara [4 ]
Lu, Sophie [5 ]
Khadka, Prasidda [1 ]
Langhnoja, Jaldeep [6 ]
Phoenix, Tim [6 ]
Ligon, Keith [1 ]
Bandopadhayay, Pratiti [7 ]
Beroukhim, Rameen [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Medford, MA USA
[3] Dana Farber Canc Inst, Stoughton, MA USA
[4] Harvard Med Sch, Brookline, MA USA
[5] Dana Farber Canc Inst, Gilbert, AZ USA
[6] UC Coll Pharm, Cincinnati, OH USA
[7] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DDRE-14
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [1] OPTIMIZING MDM2 INHIBITION FOR THE TREATMENT OF GLIOBLASTOMA
    Rendo, Veronica
    Lee, Eudocia
    Khuu, Nicholas
    Pelton, Kristine
    Lapinskas, Emily
    Wen, Patrick Y.
    Ligon, Keith
    Beroukhim, Rameen
    [J]. NEURO-ONCOLOGY, 2022, 24 : 213 - 213
  • [2] Treatment of high-grade glioma in children
    Betul Cakir, Fatma
    Kebudi, Rejin
    [J]. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2013, 28 (01): : 44 - 50
  • [3] Bevacizumab for the treatment of high-grade glioma
    Khasraw, Mustafa
    Simeonovic, Marcelle
    Grommes, Christian
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (08) : 1101 - 1111
  • [4] MDM2/4 AMPLIFICATION AND RISK OF HYPERPROGRESSION IN HIGH-GRADE GLIOMAS TREATED WITH CHECKPOINT INHIBITORS
    Donovan, Laura
    Schulte, Jessica
    Kreisl, Teri
    Welch, Mary
    Lassman, Andrew B.
    Iwamoto, Fabio
    [J]. NEURO-ONCOLOGY, 2018, 20 : 158 - 158
  • [5] A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification
    Guerin, Maxime
    Thariat, Juliette
    Ouali, Mounia
    Bouvier, Corinne
    Decouvelaere, Anne-Valerie
    Cassagnau, Elisabeth
    Aubert, Sebastien
    Lepreux, Sebastien
    Coindre, Jean-Michel
    Valmary-Degano, Severine
    Larousserie, Frederique
    Meilleroux, Julie
    Projetti, Fabrice
    Stock, Nathalie
    Galant, Christine
    Marie, Beatrice
    Peyrottes, Isabelle
    de Pinieux, Gonzague
    Gomez-Brouchet, Anne
    [J]. HUMAN PATHOLOGY, 2016, 50 : 70 - 78
  • [6] Treatment of high-grade glioma in children and adolescents
    MacDonald, T. J.
    Aguilera, D.
    Kramm, C. M.
    [J]. NEURO-ONCOLOGY, 2011, 13 (10) : 1049 - 1058
  • [7] Profile of nimotuzumab in the treatment of high-grade glioma
    Yang, Qun-ying
    Guo, Cheng-cheng
    Chen, Zhong-ping
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 819 - 825
  • [8] Treatment of high-grade glioma with radiolabeled peptides
    Waitz, Dietmar
    Putzer, Daniel
    Kostron, Herwig
    Virgolini, Irene Johanna
    [J]. METHODS, 2011, 55 (03) : 223 - 229
  • [9] MDM2 Inhibition as a New Treatment Approach in AML
    Konopleva, Marina
    [J]. ANNALS OF HEMATOLOGY, 2019, 98 : S74 - S75
  • [10] MDM2 and CDK4 lmmunohistochemical Coexpression in High-grade Osteosarcoma: Correlation With a Dedifferentiated Subtype
    Yoshida, Akihiko
    Ushiku, Tetsuo
    Motoi, Toru
    Beppu, Yasuo
    Fukayama, Masashi
    Tsuda, Hitoshi
    Shibata, Tatsuhiro
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (03) : 423 - 431
12345